DISCERN™ PKCƐ Assay for Alzheimer’s Disease Measuring synaptic dysfunction to inform a highly accurate diagnose Alzheimer’s Dementia in early dementia.
DISCERN™ Morphometric Imaging Assay for Alzheimer’s Disease Accurately informs diagnosis of Alzheimer’s Disease in early dementia, even in the presence of Mixed dementia
Clinical Study of Novel Skin Biomarker Test for Alzheimer’s Disease Gains Vigorous Physician Support in Long-Sought Early Detection Breakthrough
The Burden of Diagnosis: How physicians confront diagnosing Alzheimer’s disease with influx of patients seeking disease modifying therapies
FDA Approval of New Drug for Alzheimer’s Disease Underscores Need for DISCERN™ Accurate Diagnostic Testing Prior to Prescribing LEQEMBI™ and Finalizing Coverage
Honoring Caregivers, Patients and Families During Caregivers and Alzheimer’s Awareness Month
SYNAPS Dx Publishes First Autopsy-Confirmed Results for Identifying Alzheimer’s in Presence of Other Co-Morbid Pathologies Using DISCERN™ Test
Spotlighting Accurate, Early Diagnosis of Alzheimer’s Disease: World Alzheimer’s Month
Input your search keywords and press Enter.